Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
Personalis Inc (PSNL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.7 | 2.1 | -0.4 | 3.2 | 0.1 | -11 | -9.6 | 2.4 | -8.6 | -15 | -16 | -2.5 | -12 | -26 | -18 | -15 | -11 | -27 | -15 | -17 | -16 | -10 | -17 | -13 | -20 | -11 | -6.2 | -7.8 | -18 | -13 | -22 | -22 | -22 | -79 | |
| 0.5 | 0.7 | 0.9 | 1.0 | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.4 | 1.5 | 1.6 | 1.8 | 1.8 | 1.9 | 3.0 | 2.8 | 2.8 | 2.8 | 2.9 | 2.8 | 2.8 | 2.8 | 2.5 | 2.6 | 2.5 | 2.5 | 2.5 | 2.4 | 9.8 | |
| 0.2 | 0.4 | 0.3 | 0.4 | 0.6 | 1.6 | 1.4 | 1.2 | 1.2 | 1.8 | 1.7 | 3.5 | 3.1 | 3.6 | 3.7 | 4.0 | 4.8 | 4.4 | 4.4 | 5.8 | 3.7 | 3.5 | 3.5 | 3.4 | 2.7 | 2.7 | 2.7 | 2.7 | 2.2 | 2.8 | 2.1 | 2.3 | 2.6 | 9.8 | |
| 0.3 | 3.9 | 2.1 | – | 1.0 | 3.2 | 3.5 | 1.9 | 1.5 | 2.2 | 2.2 | 4.2 | 3.1 | 4.7 | 3.7 | 4.1 | 4.9 | 4.4 | 4.4 | 5.9 | 3.8 | 3.6 | 9.9 | – | – | – | – | – | – | – | – | – | – | – | |
| 5.3 | 4.7 | 0.3 | 5.1 | 3.7 | -9.4 | -7.4 | 5.8 | -2.4 | -9.7 | -10 | 5.1 | -4.8 | -17 | -6.9 | -2.5 | 7.8 | -6.5 | 4.4 | 4.9 | 4.9 | 7.6 | -0.3 | 1.2 | -8.0 | 0.0 | 1.6 | 3.9 | -6.0 | 2.4 | -4.2 | -2.4 | 3.6 | -0.7 | |
| 1.3 | 3.9 | 1.9 | 0.7 | 1.0 | 1.8 | 3.7 | 1.9 | 0.1 | 0.8 | 1.6 | 0.8 | 0.4 | 4.1 | 3.0 | 3.6 | 8.6 | 10 | 21 | 9.5 | 3.8 | 2.7 | 0.9 | 3.5 | 0.1 | 0.0 | 0.2 | 1.2 | 2.5 | 0.3 | 1.6 | 0.1 | 3.2 | 5.2 | |
| -1.3 | -3.9 | -1.9 | -0.7 | -1.0 | -1.8 | -44 | -35 | 0.0 | -7.6 | 5.6 | -63 | -83 | -47 | 30 | 40 | -3.2 | 23 | 11 | 22 | 14 | 20 | -8.6 | -12 | 6.3 | 13 | -28 | -26 | -23 | -4.4 | 19 | -14 | -46 | -46 | |
| 0.0 | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | – | – | 0.1 | 0.4 | 145 | 145 | 145 | 0.3 | – | – | – | 163 | 1.7 | 0.5 | 1.3 | 0.5 | 1.4 | 0.0 | 0.5 | – | 2.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.2 | -0.2 | -0.2 | – | 15 | -20 | -20 | – | – | – | 4.4 | 4.4 | 4.4 | 4.4 | -1.0 | -1.9 | -1.9 | -1.9 | 0.8 | -1.9 | -1.9 | -1.9 | -0.4 | – | – | – | -0.3 | -0.3 | 2.3 | -1.0 | -0.4 | -0.3 | -3.4 | -5.1 | |
| -0.2 | -0.2 | -0.2 | 0.0 | 14 | 143 | -23 | 0.5 | 0.3 | 1.3 | 119 | 0.9 | 163 | 6.0 | -0.5 | 1.3 | 0.5 | -0.4 | 0.8 | 0.5 | 0.9 | 0.9 | 0.3 | 9.8 | 1.1 | 1.5 | 62 | 50 | 20 | -0.3 | -0.3 | 111 | 18 | 128 | |
| -0.8 | -2.1 | -2.6 | 2.6 | 13 | 130 | -76 | -32 | -8.4 | -22 | 108 | -65 | 69 | -67 | 11 | 26 | -14 | -4.9 | -3.2 | 5.6 | -2.0 | 10 | -25 | -15 | -13 | 3.8 | 28 | 16 | -20 | -18 | -3.4 | 74 | -51 | 2.6 | |
| -0.6 | -1.9 | -2.4 | 2.5 | -0.9 | -13 | -13 | 0.5 | -8.7 | -16 | -18 | -3.4 | -12 | -30 | -21 | -19 | -20 | -38 | -36 | -26 | -20 | -13 | -18 | -17 | -21 | -11 | -6.4 | -9.0 | -20 | -13 | -23 | -22 | -26 | -85 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.